# New Chinese weight-loss drug produces bigger results than Wegovy in under a year

- URL: https://talkfuse.com/story/new-chinese-weight-loss-drug-produces-bigger-results-than-wegovy-in-under-a-year/
- Published: 2026-11-16T16:02:14+00:00
- Updated: 2026-11-16T16:24:07+00:00
- Original publisher: New York Post (publisher lean: Right)
- Original article: https://nypost.com/2026/11/16/health/new-chinese-weight-loss-drug-produces-bigger-results-than-wegovy/
- Topics: Asia, Health, Medicine, World

## Key points

- Ribupatide users lost up to 17.7% of their weight in 48 weeks.
- The trial involved 567 adults and three weekly dose levels.
- Digestive side effects were common, while several health measures improved.

## Summary

A 48-week trial found that the experimental Chinese drug ribupatide helped participants lose an average of up to 17.7% of their starting weight. The results put it in a similar range to, or above, those reported for Wegovy in a separate, longer trial, though the studies cannot be directly compared.

Researchers at Fudan University studied 567 adults with overweight or obesity, who received one of three weekly ribupatide doses or a placebo alongside diet and exercise advice. Weight loss ranged from 10.7% at the lowest dose to 17.7% at the highest, and the higher-dose groups had not yet reached a plateau. Participants also saw improvements in blood sugar, blood pressure and cholesterol; common side effects included nausea, vomiting and diarrhoea. Hengrui is developing the drug with US biotech firm Kailera Therapeutics for markets outside China.

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.
